In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...
14d
Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...
What is the Fund Sentiment? There are 1478 funds or institutions reporting positions in GSK plc - Depositary Receipt (). This is an increase of 30 owner(s) or 2.07% in the last quarter.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback